Hi guys,
I am working with RNA-seq data generated by Illumina GAII. The experiment design is a randomized complete block design (RCBD) with 4 different tissues, 2 treatments (control and treated), and 3 blocks (reps). My interest is to use the mixed ANOVA in ProcMixed (SAS) to determine differentially expressed genes. Initially, I thought I can normalize read counts in RPKM and use that to do the Mixed ANOVA in SAS or JMP Genomics. Reading through the literature I realized that RPKM is not the best normalization tool for RNA-seq. I am leaning toward DESeq or edgeR for normalization.
My questions are:
1) How do I extract normalized counts from DESeq and EdgeR?
2) Has anybody tried to analyze differential gene expression in normalized data using ProcMixed in SAS? Is there anything I should be cautious in using mixed effect model for RNA-seq? I don't think I can use DESeq and edgeR for a mixed model.
I appreciate your input.
Thanks.
T. Abebe
I am working with RNA-seq data generated by Illumina GAII. The experiment design is a randomized complete block design (RCBD) with 4 different tissues, 2 treatments (control and treated), and 3 blocks (reps). My interest is to use the mixed ANOVA in ProcMixed (SAS) to determine differentially expressed genes. Initially, I thought I can normalize read counts in RPKM and use that to do the Mixed ANOVA in SAS or JMP Genomics. Reading through the literature I realized that RPKM is not the best normalization tool for RNA-seq. I am leaning toward DESeq or edgeR for normalization.
My questions are:
1) How do I extract normalized counts from DESeq and EdgeR?
2) Has anybody tried to analyze differential gene expression in normalized data using ProcMixed in SAS? Is there anything I should be cautious in using mixed effect model for RNA-seq? I don't think I can use DESeq and edgeR for a mixed model.
I appreciate your input.
Thanks.
T. Abebe

atient, which is good since you can't actually measure it (you can try, but you'll just get an error). Phenotype is a linear combination of patients, so ~patient + phenotype*time would make more sense (whether to include "phenotype" and/or "time" on their own in the model will depend on the biology).
. I thought that even if it is possible to introduce a "batch factor" as fixed effect, one would loose a lot of power because more degrees of freedom are consumed compared to treating the batch effect as random. And the more levels your "batch factor" has, the more you benefit from treating it as random ?
Comment